Type 2 Diabetes – Cardiovascular Disease Risk

Medical Condition: Diabetes (Type 2 Diabetes)

Facility/Clinic: PMG Research of Wilmington

Age: 50 or older

Gender: Male/Female


A research study is evaluating whether semaglutide tablets reduce the risk of stroke and heart attack in people with type 2 diabetes.

This research study may be an option if you: 

•    Have been diagnosed with type 2 diabetes

•    Have an HbA1c between 6.5 – 10%

•    Have at least ONE of the following cardiovascular conditions:

– Prior heart attack, stent placement or stenosis 

– History of stroke

– Peripheral Artery Disease (PAD)

– Chronic kidney disease

Other criteria apply.  Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care along with regular health and medical testing (including access to glucose testing equipment) at no cost.

Enrollment: Open

Patient Commitment Duration: Approximately 3-5 years

Number of visits in study: Approximately 26 clinic visits

Patient Compensation: Financial compensation may be provided for time and travel expenses

Apply for this study below:

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.